• Latest Posts

UPDATE: Future of CAR-T shaken by Novartis R&D Shuffle

Meet the Cyborg Bacteria that Culture Themselves

Here comes the First-ever Combination Therapy for Multiple Sclerosis

CRISPR Thx’ surprisingly low IPO… why are Investors Discouraged?

And the highest funding in Europe this year goes to… Antibody-Drug Conjugates!

ADVERTISEMENT

Tailored Cancer Vaccines? NousCom is working on it!

Interview: GeNeuro’s CFO explains its Unique Multiple Sclerosis Treatment

Interview: This Biotech Could Have the First HIV Cure on the Market

ITW: Prexton Therapeutics CEO explains Development of new Parkinson’s Drug

UPDATE: AC Immune rakes in €52.5M IPO for assault on Alzheimers

Terrible Turing hasn’t given up on Toxoplasmosis (or its Karma)

ADVERTISEMENT